Advanstar's Savage, PMI's Bennicasa win Nexus Awards

Share this article:
Advanstar's Debby Savage and Pharmaceutical Media Inc.'s Gina Bennicasa won the Association of Medical Media's 17th annual Nexus Representatives of the Year Awards, honoring outstanding sales professionals in medical publishing.

Savage won the award for multi-specialty publication for her work on Medical Economics. Bennicasa, of PMI, a New York City marketing and sales representation firm, won the award for specialty publication for her work representing Elsevier's American College of Cardiology properties, including both print and online.

The awards luncheon was held today at the Palace Hotel in midtown Manhattan. Keynote speaker Harry Sweeney, formerly of Dorland Global and now managing partner, SouthPennSquare Associates, discussed the journal advertising recession and laced into marketers pulling back on print ads, noting AMM research showing that journal ads deliver a higher ROI than any other channel.

“What part of Number One don't these people get?” asked Sweeney. “Why are pages dropping in the face of this evidence?” He added, getting a guffaw out of the crowd: “Are you the worst sales people in the world?”
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...